ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Actuate Therapeutics Inc

Actuate Therapeutics Inc (ACTU)

8.235
-0.165
( -1.96% )
Updated: 13:42:11

Actuate Therapeutics Inc Financial Summary

The current ACTU market cap is 160.84M. The company's latest EPS is USD -1.2669 and P/E is -6.51.

Quarter End Mar 2024Jun 2024
USD ($)
Total Revenue 00
Operating Income -7.77M-5.44M
Net Income -8.3M-6.57M
Year End December 30 2023 2023
USD ($)
Total Revenue 0
Operating Income -24.97M
Net Income -24.75M
Quarter End Mar 2024Jun 2024
USD ($)
Total Assets 2.7M1.73M
Total Liabilities 16.3M21.81M
Total Equity -107.77M-114.26M
Year End December 30 2023 2023
USD ($)
Total Assets 3M
Total Liabilities 8.44M
Total Equity -99.63M
Quarter End Mar 2024Jun 2024
USD ($)
Operating -5.25M-7.92M
Investing N/A N/A
Financing 4.36M5.31M
Year End December 30 2023 2023
USD ($)
Operating -21.63M
Investing N/A
Financing 4.14M
Market Cap 160.84M
Price to Earnings Ratio -6.51
Price to Sales Ratio 0
Price to Cash Ratio 54.46
Price to Book Ratio -29.58
Dividend Yield -

Share Statistics

Shares Outstanding 19.53M
Average Volume (1 week) 72.08k
Average Volume (1 Month) 75.24k
52 Week Change 64.70%
52 Week High 10.162
52 Week Low 5.00
Spread (Intraday) 0.25 (2.95%)

Company Info

Company Name Actuate Therapeutics Inc
Address 108 lakeland ave
dover, delaware 19901
Website https://www.actuatetherapeutics.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock